| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net (loss) income | -4,100 | 900 | -1,367,000 | 20,900 |
| Profits interest distribution expenses | NaN | 0 | 1,379,700 | NaN |
| Net realized gains on investments | 100 | 1,700 | 3,500 | 2,700 |
| Net unrealized gains on investments | 0 | 2,200 | 36,000 | 1,200 |
| Earnings from equity method investments | 200 | 300 | 300 | 1,200 |
| Share-based compensation expenses | 28,800 | 20,500 | 17,200 | 5,400 |
| Depreciation and amortization | 10,000 | 9,500 | 10,000 | 15,700 |
| Deferred income tax (benefit) expense | -400 | -20,200 | -1,100 | -10,700 |
| Net gain on commutation | NaN | 0 | NaN | NaN |
| Net foreign exchange losses | -1,900 | -5,300 | 2,400 | -17,300 |
| Net accretion of discount on fixed maturity securities and short-term investments | 1,500 | 1,700 | 2,000 | 3,900 |
| Other, net | -200 | -200 | -2,400 | -400 |
| Premiums receivable | 110,000 | 155,900 | -10,000 | 112,700 |
| Ceded unearned premiums | 40,900 | -54,700 | -44,500 | 325,100 |
| Insurance balances payable | NaN | NaN | 42,600 | -19,200 |
| Reinsurance recoverables on unpaid losses and loss adjustment expenses | 82,700 | 128,800 | 133,400 | 327,100 |
| Other reinsurance recoverables | 86,600 | 66,500 | 40,100 | 112,700 |
| Deferred acquisition costs | 7,800 | 17,600 | 7,900 | -9,800 |
| Unpaid losses and loss adjustment expenses | 142,200 | 161,700 | 162,400 | 321,200 |
| Unearned premiums | 61,800 | -4,800 | 9,200 | 282,900 |
| Payables to reinsurers | 27,200 | 800 | -166,800 | 253,100 |
| Deferred ceding commissions | 10,000 | 6,800 | -10,800 | 59,500 |
| Funds held under reinsurance | 22,700 | -67,900 | -152,200 | -230,900 |
| Other assets, accounts payable and other liabilities | -53,500 | -156,700 | -15,000 | -8,700 |
| Net cash (used in) provided by operating activities | -21,400 | 61,900 | 73,900 | 309,300 |
| Proceeds From Sale Of | 44,300 | 0 | 0 | 0 |
| Proceeds From Sale Of | NaN | 0 | 1,100 | NaN |
| Other investments | NaN | 0 | 3,600 | NaN |
| Maturities of fixed maturity securities | 14,100 | 9,800 | 11,100 | 28,900 |
| Payments To Acquire | 91,000 | -397,900 | 135,000 | 262,900 |
| Equity method investments | 1,300 | 800 | 400 | 400 |
| Net change in short-term investments | 161,200 | -23,600 | -15,100 | 10,200 |
| Purchases of subsidiaries, net of cash acquired | 9,400 | 0 | 8,500 | 1,400 |
| Capitalized technology development expenditures | 6,700 | 11,600 | 12,500 | 17,300 |
| Other, net | 400 | 200 | 0 | 300 |
| Net cash used in investing activities | -211,600 | 64,700 | -55,500 | -182,800 |
| Issuance of common shares, net of issuance costs | NaN | 0 | 392,000 | NaN |
| Redemption of class c convertible preference shares | NaN | 0 | 175,300 | NaN |
| Issuance of convertible preference shares, net of issuance costs | NaN | 0 | NaN | NaN |
| Credit facility borrowings | NaN | 0 | 0 | 5,000 |
| Credit facility repayment | NaN | 0 | 5,000 | 0 |
| Issuance of debt, net of issuance costs | NaN | 0 | 0 | NaN |
| Acquisition of common shares | 12,200 | NaN | NaN | NaN |
| Payment of debt | 800 | 800 | 0 | NaN |
| Acquisition of non-controlling interests in subsidiaries | 4,900 | -5,100 | 3,100 | 4,100 |
| Dividends paid to non-controlling interests | 1,300 | 8,000 | NaN | NaN |
| Net cash used in financing activities | -19,200 | -3,700 | 208,600 | 900 |
| Net decrease in cash, cash equivalents and restricted cash | -252,200 | 122,900 | 227,000 | 127,400 |
| Effect of foreign currency rate changes on cash, cash equivalents and restricted cash | -10,600 | 500 | 48,500 | NaN |
| Cash, cash equivalents and restricted cash at beginning of period | 1,799,300 | 1,675,900 | 1,273,000 | NaN |
| Cash, cash equivalents and restricted cash at end of period | 1,536,500 | 1,799,300 | 1,675,900 | NaN |
Accelerant Holdings (ARX)
Accelerant Holdings (ARX)